Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.2880
-0.0129 (-4.29%)
Jan 6, 2026, 4:00 PM EST - Market closed
Milestone Scientific Revenue
Milestone Scientific had revenue of $2.36M in the quarter ending September 30, 2025, a decrease of -6.11%. This brings the company's revenue in the last twelve months to $8.93M, up 0.59% year-over-year. In the year 2024, Milestone Scientific had annual revenue of $8.63M, down -12.19%.
Revenue (ttm)
$8.93M
Revenue Growth
+0.59%
P/S Ratio
2.62
Revenue / Employee
$525,266
Employees
17
Market Cap
22.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.63M | -1.20M | -12.19% |
| Dec 31, 2023 | 9.83M | 1.02M | 11.60% |
| Dec 31, 2022 | 8.81M | -1.50M | -14.54% |
| Dec 31, 2021 | 10.30M | 4.87M | 89.52% |
| Dec 31, 2020 | 5.44M | -2.94M | -35.07% |
| Dec 31, 2019 | 8.37M | -1.25M | -12.97% |
| Dec 31, 2018 | 9.62M | -1.66M | -14.71% |
| Dec 31, 2017 | 11.28M | 799.88K | 7.63% |
| Dec 31, 2016 | 10.48M | 990.44K | 10.43% |
| Dec 31, 2015 | 9.49M | -841.52K | -8.14% |
| Dec 31, 2014 | 10.33M | 321.67K | 3.21% |
| Dec 31, 2013 | 10.01M | 1.36M | 15.76% |
| Dec 31, 2012 | 8.65M | 270.15K | 3.22% |
| Dec 31, 2011 | 8.38M | -1.37M | -14.07% |
| Dec 31, 2010 | 9.75M | 1.20M | 14.05% |
| Dec 31, 2009 | 8.55M | 1.93M | 29.07% |
| Dec 31, 2008 | 6.62M | 233.09K | 3.65% |
| Dec 31, 2007 | 6.39M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
MLSS News
- 16 hours ago - Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry - GlobeNewsWire
- 7 weeks ago - Milestone Scientific Inc. (MLSS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025 - GlobeNewsWire
- 7 weeks ago - Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call - GlobeNewsWire
- 3 months ago - Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership - GlobeNewsWire
- 3 months ago - Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification - GlobeNewsWire
- 3 months ago - Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management - GlobeNewsWire
- 5 months ago - Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025 - GlobeNewsWire